Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
35,503,222
-
Share change
-
+2,211,416
-
Total reported value
-
$449,065,381
-
Price per share
-
$12.65
-
Number of holders
-
70
-
Value change
-
+$27,105,726
-
Number of buys
-
46
-
Number of sells
-
17
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q3 2021
As of 30 Sep 2021,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,503,222 shares.
The largest 10 holders included
Novo Holdings A/S, Vivo Capital, LLC, CITADEL ADVISORS LLC, FMR LLC, Sofinnova Investments, Inc., RA CAPITAL MANAGEMENT, L.P., Pivotal bioVenture Partners Investment Advisor LLC, Rock Springs Capital Management LP, BlackRock Inc., and SUVRETTA CAPITAL MANAGEMENT, LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.